Data as of Nov 4, 2026.
AIPI vs BIOY: Dividend Yield & Total Return
AIPI and BIOY both write options for income.
askIQ about this page
askIQ about AIPI and BIOY
Net assets on Nov 3, 2026: $446m for REX AI EQUITY PREMIUM INCOME ETF and $1.5m for GraniteShares YieldBOOST Biotech ETF.
Not measured
AIPI over 1 year: paid 29.2%, price −24.8%, total +5.3%, not measured against a benchmark. Data to Nov 4, 2026.
AIPI
+5.3%
29.2% as cash
Total return, distributions reinvested
Not measured
AIPI over 1 year: paid 29.2%, price −24.8%, total +5.3%, not measured against a benchmark. Data to Nov 4, 2026.
AIPI
+5.3%
29.2% of it arrived as cash. Total return, distributions reinvested. AIPI over 1 year: paid 29.2%, price −24.8%, total +5.3%, not measured against a benchmark. Data to Nov 4, 2026.
Data to Nov 4, 2026.13.6 pts behind XBI
BIOY since launch: paid 26.1%, price −21.9%, total +5.4%, XBI +19.0%, −13.6 pts. Data to Nov 4, 2026.
XBI
+19.0%
BIOY
+5.4%
26.1% as cash
13.6 pts behind XBI
Total return, distributions reinvested
13.6 pts behind XBI
BIOY since launch: paid 26.1%, price −21.9%, total +5.4%, XBI +19.0%, −13.6 pts. Data to Nov 4, 2026.
XBI
+19.0%
BIOY
+5.4%
13.6 pts behind XBI
26.1% of it arrived as cash. Both charts share one scale, with zero at the line. BIOY since launch: paid 26.1%, price −21.9%, total +5.4%, XBI +19.0%, −13.6 pts. Data to Nov 4, 2026.
Data to Nov 4, 2026.Pair scorecard
AIPI costs 0.53 points a year less; AIPI is far larger, $446m against $1.5m.
Points (pts) are percentage points.
| Measure | AIPI | BIOY |
|---|---|---|
| Paid and earned | ||
| Total return, 1 year | +5.3% | not published |
| Price change | fell 24.8% (1 year) | fell 21.9% (since May 5, 2026) |
| Return of capital, issuer estimate | 100% of the Oct 22, 2026 payment | 96% of the Sep 22, 2026 payment |
| Against its benchmark | ||
| Benchmark | not published | Biotech, measured through XBI |
| Cost and size | ||
| Expense ratio | 0.65% | 1.18% |
| Net assets, as of Nov 3, 2026 | $446m | $1.5m |
| Holdings | ||
| Holdings in common | 0% | |
What they share
By the books each fund has filed, AIPI and BIOY hold 0% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Aug 31, 2026.
half
0% in common
Only in one fund ↓
Side by side
As of Nov 4, 2026. Source: ETFIQ. Cash paid: distributions over the window, as a share of the starting price. Payout rate: the latest payment, annualized, over today’s price.
Window by window
| Total return | Cash paid | Against the benchmark | ||||
|---|---|---|---|---|---|---|
| Window | AIPI | BIOY | AIPI | BIOY | AIPI | BIOY |
| 3 months | −3.8% | +6.9% | 8.7% | 14.5% | not measured | +2.9 pts |
| 6 months | +4.5% | +4.4% | 16.2% | 25.9% | not measured | −11.3 pts |
| 1 year | +5.3% | – | 29.2% | – | not measured | – |
| Since launchNot the same days: AIPI Jun 2024 · BIOY May 2026 | +42.9% | +5.4% | 67.5% | 26.1% | not measured | −13.7 pts |
– means no data for this window. Open this comparison in the app →
AIPI
Over the year to Nov 4, 2026, AIPI paid 29.2% of its starting value in cash distributions while its price fell 24.8%. With every distribution reinvested, the fund returned +5.3%. At its price on Nov 4, 2026 the latest distribution annualizes to 35.0%, paid weekly. REX estimates that 100% of the distribution paid Oct 22, 2026 was a return of capital (its 19a-1 notice). That is a tax label, not a measure of erosion.
BIOY
Over the period from its first trade on May 5, 2026 to Nov 4, 2026, BIOY paid 26.1% of its starting value in cash distributions while its price fell 21.9%. With every distribution reinvested, the fund returned +5.4%. Biotech (XBI) returned +19.0% over the same days, so a holder was behind by 13.6 pts. At its price on Nov 4, 2026 the latest distribution annualizes to 60.7%, paid weekly. GraniteShares estimates that 96% of the distribution paid Sep 22, 2026 was a return of capital (its 19a-1 notice).
Questions people ask
Links are sources, not endorsements. A comparison is not a recommendation.
How this is computed
Overlap adds up the smaller of the two weights for each security both funds hold.
Every number is an ETFIQ calculation with distributions reinvested.
Cite this pageCitation, APA and Markdown
ETFIQ, AIPI against BIOY, data as of Nov 4, 2026. https://etfiq.com/compare/income/aipi-vs-bioy
ETFIQ. (Nov 4, 2026). AIPI against BIOY. Retrieved from https://etfiq.com/compare/income/aipi-vs-bioy
[AIPI against BIOY (ETFIQ, Nov 4, 2026)](https://etfiq.com/compare/income/aipi-vs-bioy)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.